What is the treatment for an acute asthma attack in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Asthma Attack in Adults

Immediately administer nebulized short-acting beta-2 agonist (salbutamol 5 mg or terbutaline 10 mg) with oxygen 40-60% and oral prednisolone 30-60 mg, then reassess at 15-30 minutes to determine disposition. 1, 2, 3

Initial Assessment and Severity Classification

Assess severity objectively using peak expiratory flow (PEF), respiratory rate, heart rate, and ability to complete sentences—never rely on clinical impression alone. 1, 2, 3

Moderate Asthma (treat at home if appropriate):

  • Speech normal 1
  • Pulse <110 beats/min 1
  • Respiration <25 breaths/min 1
  • PEF >50% predicted or personal best 1

Acute Severe Asthma (strongly consider admission):

  • Cannot complete sentences in one breath 1, 2
  • Pulse >110 beats/min 1, 2
  • Respiration >25 breaths/min 1, 2
  • PEF <50% predicted or personal best 1, 2

Life-Threatening Features (immediate ICU consideration):

  • PEF <33% predicted 1, 3
  • Silent chest, cyanosis, feeble respiratory effort 1, 3
  • Exhaustion, confusion, drowsiness, or coma 1, 3
  • Bradycardia, hypotension, or respiratory arrest 1, 3

First-Line Treatment (Within 15-30 Minutes)

Oxygen Therapy:

  • Administer 40-60% oxygen immediately to maintain saturation >90% 1, 3
  • Use oxygen as the driving gas for nebulizers whenever possible 3, 4

Nebulized Beta-2 Agonist:

  • Salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer 1, 2, 3
  • Repeat every 20 minutes for 3 doses initially 3, 5
  • If no nebulizer available, use metered-dose inhaler with large-volume spacer: 4-8 puffs every 20 minutes 1, 3

Systemic Corticosteroids:

  • Oral prednisolone 30-60 mg immediately (preferred route) 1, 2, 3
  • Alternative: IV hydrocortisone 200 mg if unable to take oral 1
  • Oral administration is as effective as IV and strongly preferred 3, 6
  • Clinical benefits may not occur for 6-12 hours, so early administration is critical 7, 6

Reassessment at 15-30 Minutes

Measure PEF, vital signs, oxygen saturation, and clinical response—response to treatment predicts hospitalization need better than initial severity. 1, 3

If PEF >75% predicted/best:

  • Step up usual maintenance treatment 1
  • Arrange follow-up within 48 hours 1
  • Provide PEF meter and self-management plan 1

If PEF 50-75% predicted/best:

  • Continue prednisolone 30-60 mg 1
  • Continue nebulized beta-2 agonist every 4 hours 1
  • Reassess before discharge; must be stable for 60 minutes 1

If PEF <50% or any severe features persist:

  • Arrange immediate hospital admission 1
  • Continue oxygen and steroids 1
  • Increase nebulized beta-2 agonist frequency to every 30 minutes 1
  • Add ipratropium bromide 0.5 mg to nebulizer, repeat every 6 hours 1, 8

Additional Therapies for Severe/Life-Threatening Asthma

Ipratropium Bromide:

  • Add 0.5 mg to nebulized beta-2 agonist for severe exacerbations 1, 7, 8
  • Combination provides 16-32% greater improvement in PEF than salbutamol alone 8
  • Benefits are primarily in emergency department; not sustained after hospital admission 7

IV Magnesium Sulfate:

  • Consider 2 g over 20 minutes for severe exacerbations not responding to initial therapy 3
  • Recommended for life-threatening presentations 3

Aminophylline:

  • Reserved only for life-threatening features with inadequate response 1
  • NOT recommended in first 4 hours of therapy due to increased side effects without superior efficacy 3, 6
  • If used: 5 mg/kg IV over 20 minutes, then 1 mg/kg/h maintenance 1
  • Omit loading dose if patient already taking oral theophyllines 1

Critical Pitfalls to Avoid

Never underestimate severity based on clinical impression alone—always use objective measurements (PEF, oxygen saturation). 1, 2, 3

Do not administer sedatives of any kind in acute asthma. 3

Do not delay systemic corticosteroids—underuse of corticosteroids is a major factor in preventable asthma deaths. 1

Do not routinely prescribe antibiotics unless strong evidence of bacterial infection exists. 3

Do not use methylxanthines (theophylline) routinely due to increased side effects without superior efficacy. 3, 4

Hospital Admission Criteria

Admit if any of the following present after initial treatment: 1

  • Any life-threatening features 1
  • PEF <33% predicted 1
  • Any features of acute severe asthma persist after initial treatment 1

Lower threshold for admission if: 1

  • Attack occurs in afternoon or evening 1
  • Recent hospital admission or previous severe attacks 1
  • Recent nocturnal symptoms 1
  • Patient unable to assess own condition or poor social circumstances 1

ICU Transfer Indications

Transfer to ICU accompanied by physician prepared to intubate if: 1

  • Deteriorating PEF or worsening exhaustion 1
  • Feeble respirations, persistent hypoxia, or hypercapnia 1
  • Coma, respiratory arrest, confusion, or drowsiness 1

Discharge Planning

Patients should only be discharged when: 1

  • Stable on discharge medication for 24 hours 1
  • PEF >75% predicted or personal best 1
  • Inhaler technique checked and recorded 1
  • Prescribed oral corticosteroids (30-60 mg prednisolone daily for 7-14 days, no taper needed) 3, 6
  • Prescribed inhaled corticosteroids in addition to bronchodilators 1, 6
  • Provided PEF meter and self-management plan 1
  • GP follow-up arranged within 1 week 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adult Asthma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Acute Asthma Exacerbation in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.